AV-1980R
AssetVaccine
Investigational preventive vaccine inducing immune responses against pathological tau protein
- Stage
- Phase 1
- Modality
- Vaccine
- Target
- MAPT
- Indications
- 1
- Trials
- 0
- Developers
- 2
Indications
1Alzheimer's disease
Phase 1prnewswire.com7 Oct 2026
- Targets and what it contains2
- Owner and partners4
- Evidence for its targets2
- Competitors12
- Aging relevance1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 1 source